Stocks · Healthcare · Medical - Care Facilities
DaVita Inc. DVA
$178.69 +1.33% Close, Oct 2, 2026 · NYSE · Market cap $11.47B
Inexpensive vs sector
Next earnings report: Nov 4, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- The diluted share count fell 14.6% in a year, mainly through buybacks.
- Net debt is 3.7× EBITDA, a high level of leverage.
- The stock is in an uptrend: above its 200-day average for 168 trading days, with the 50-day average above the 200-day.
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 5, 2026.
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Bottom 44%
- EPS growth (TTM, YoY)Top 47%
- FCF growth (TTM, YoY)Top 42%
- Revenue growth, 3-year CAGRBottom 39%
- Revenue growth accelerationTop 49%
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalTop 13%
- Gross marginBottom 20%
- Operating marginTop 18%
- Cash conversion (OCF / net income)Top 25%
- Accruals (lower is better)Top 45%
- Net debt / EBITDA (lower is better)Bottom 22%
- Interest coverTop 30%
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldTop 7%
- Free-cash-flow yieldTop 4%
- EBITDA / enterprise valueTop 6%
- Sales / enterprise valueTop 18%
- P/E vs own 5-year history (lower is better)Bottom 42%
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthTop 41%
- 6-month returnTop 37%
- 1-year return vs S&P 500Top 33%
- Distance from 52-week highTop 43%
- Trend checklist (0–4)Top 39%
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersBottom 45%
- Consecutive EPS beatsTop 25%
- Share of analysts rating BuyBottom 11%
- Upside to consensus price targetBottom 36%
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Top 37%
- Maximum drawdown, 3 yearsTop 15%
- Beta vs S&P 500 (lower is better)Top 6%
- Net debt / EBITDA (lower is better)Bottom 22%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | 6.7% | 6.4% | ↓ |
| EPS growth (YoY) | -1.5% | 11.9% | ↑ |
| Gross margin | 32.5% | 31.0% | ↓ |
| Operating margin | 15.8% | 15.1% | ↓ |
| FCF margin | 9.8% | 11.5% | ↑ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | 6.4% | 6.7% | ↓ | Bottom 44% |
| EPS growth (TTM, YoY) | 11.9% | -1.5% | ↑ | Top 47% |
| Gross margin | 31.0% | 32.5% | ↓ | Bottom 20% |
| Operating margin | 15.1% | 15.8% | ↓ | Top 18% |
| Net margin | 6.0% | 6.4% | ↓ | — |
| Free-cash-flow margin | 11.5% | 9.8% | ↑ | — |
| Return on invested capital | 11.2% | — | Top 13% | |
| Revenue growth, 3-year CAGR | 5.5% | — | Bottom 39% |
Quality of earnings and balance sheet
- Cash conversion (OCF / net income)Above 1× means profits are backed by cash.
- 2.59×
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- -7.6%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 0.9%
- Receivables growth vs revenue growthReceivables growing much faster than sales can be a warning.
- -5.5 pp
- Net debt / EBITDABelow 1× is conservative; above 3× is high leverage.
- 3.66×
- Interest cover (operating income / interest)How many times operating profit covers interest.
- 3.8×
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 1.31%
- Net buyback yield (TTM)
- 13.31%
- Shareholder yield
- 14.61%
- Share count change, 1 year
- -14.6%
- Share count change, 3-year CAGR
- -10.9%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 30, 2026 (filed Aug 4, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 3
- Beats in the last 8 reports
- 6 of 8
- Average EPS surprise, last 4
- +1.7%
- Average 2-day reaction, last 8
- +0.5%
- Positive 20 days after report
- 3 of 8
Analysts
- Consensus price target
- $235.67
- Target vs current price
- +31.9%
- Analysts with a rating
- 23
- Share rating Buy or Strong Buy
- 43%
- Consensus rating
- Hold
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Aug 4, 2026 | +3.6% | -2.4% | -21.4% | -24.7% | — |
| May 5, 2026 | +19.1% | +1.9% | +29.1% | +21.9% | +55.0% |
| Feb 2, 2026 | +4.9% | +1.7% | +28.8% | +40.8% | +37.3% |
| Oct 29, 2025 | -20.8% | -2.4% | -7.4% | -6.4% | -17.1% |
| Aug 5, 2025 | +9.3% | +0.7% | -7.5% | -1.8% | -7.1% |
| May 12, 2025 | +2.6% | +0.5% | +1.1% | -4.2% | -11.1% |
| Feb 13, 2025 | +4.7% | +2.9% | -15.2% | -18.0% | -16.4% |
| Oct 29, 2024 | -4.8% | +0.8% | -7.7% | +6.3% | +11.8% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Aug 4, 2026 | $4.02 | $3.88 | +3.6% | $3.55B |
| May 5, 2026 | $2.87 | $2.41 | +19.1% | $3.42B |
| Feb 2, 2026 | $3.40 | $3.24 | +4.9% | $3.62B |
| Oct 29, 2025 | $2.51 | $3.17 | -20.8% | $3.42B |
| Aug 5, 2025 | $2.95 | $2.70 | +9.3% | $3.38B |
| May 12, 2025 | $2.00 | $1.95 | +2.6% | $3.22B |
| Feb 13, 2025 | $2.24 | $2.14 | +4.7% | $3.29B |
| Oct 29, 2024 | $2.59 | $2.72 | -4.8% | $3.26B |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| P/E (trailing) | 15.7× | 14.8× | 52th | Top 7% |
| P/E (forward) | 12.1× | — | — | — |
| EV / EBITDA | 7.8× | — | — | Top 6% |
| EV / Sales | 1.54× | — | — | Top 18% |
| Free-cash-flow yield | 14.03% | — | — | Top 4% |
| Earnings yield | 6.37% | — | — | Top 7% |
P/E over the past five years
Range 10.5× – 20.2× since Jun 30, 2021. Each point: price on the filing date divided by trailing-twelve-month EPS known then.
What moved the stock over the past year
- Price return, 1 year
- +34.5%
- Earnings per share growth (TTM)
- +11.9%
- Change in P/E multiple
- +44.9%
Most of the move came from a change in the valuation multiple.
Technical state
Trend checklist
- ✗ Price above 20-day average
- ✗ Price above 50-day average
- ✓ Price above 200-day average
- ✓ 50-day average above 200-day
- ✗ MACD histogram positive
Trend quality
- Days above the 50-day average
- 0
- Days above the 200-day average
- 168
- 50-day average slope (20 days)
- -9.3%
- 200-day average slope (20 days)
- +3.9%
- Distance from 50-day average
- -5.7%
- Distance from 200-day average
- +5.1%
- RSI (14)
- 44.9
- Relative volume
- 0.62×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 47.9%
- Volatility vs own 5-year history
- 79th percentile · Normal for this stock
- Beta vs S&P 500 (2 years, weekly)
- 0.25
- Correlation with S&P 500
- 0.08
- Current drawdown from 1-year high
- -25.8%
- Maximum drawdown, 3 years
- -41.4%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Aug 4, 2021 | Nov 9, 2022 | -51.1% | 320 days | 329 days (Mar 5, 2024) |
| Feb 4, 2025 | Jan 14, 2026 | -41.4% | 237 days | 77 days (May 6, 2026) |
| Jul 29, 2026 | Aug 21, 2026 | -27.9% | 17 days | Not yet recovered |
| Jan 8, 2021 | Feb 22, 2021 | -19.3% | 29 days | 52 days (May 6, 2021) |
| Sep 16, 2024 | Oct 31, 2024 | -15.4% | 33 days | 16 days (Nov 22, 2024) |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $11.47B
- P/E (TTM)
- 15.7
- EPS, diluted (TTM)
- $11.38
- Revenue (TTM)
- $14.01B
- 52-week range
- $101.00 – $247.49
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $11.62B | $11.61B | $12.14B | $12.82B | $13.64B |
| Gross profit | $3.65B | $3.40B | $3.82B | $4.22B | $3.68B |
| Operating income | $1.80B | $1.34B | $1.60B | $2.09B | $2.01B |
| Net income | $978.5M | $560.4M | $691.5M | $936.3M | $746.8M |
| EPS (diluted) | $8.90 | $5.71 | $7.42 | $10.73 | $9.51 |
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $3.26B | $3.29B | $3.22B | $3.38B | $3.42B | $3.62B | $3.42B | $3.55B |
| Net income | $214.7M | $259.3M | $162.9M | $199.3M | $150.3M | $234.2M | $197.5M | $265.4M |
| EPS (diluted) | $2.50 | $3.09 | $2.00 | $2.58 | $2.04 | $2.45 | $2.87 | $4.02 |
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Operating cash flow | $1.93B | $1.56B | $2.06B | $2.02B | $1.89B |
| Capital expenditure | -$641.5M | -$603.4M | -$568.0M | -$555.4M | -$575.9M |
| Free cash flow | $1.29B | $961.1M | $1.49B | $1.47B | $1.31B |
| Dividends paid | $0 | $0 | $0 | $0 | $0 |
| Net share buybacks | -$1.60B | -$783.7M | -$255.3M | -$1.37B | -$1.77B |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $688.9M
- Total assets
- $17.71B
- Total liabilities
- $16.63B
- Total debt
- $10.78B
- Net debt
- $10.11B
- Shareholders’ equity
- -$765.1M
As of Jun 30, 2026 (filed Aug 4, 2026).
Short interest
- Shares sold short
- 4,298,025
- Days to cover
- 6.75
- Change vs previous report
- -8.1%
FINRA short interest, settlement date Sep 15, 2026.
Stock splits
- Sep 9, 2013
- 2-for-1
- Jun 16, 2004
- 3-for-2
- Oct 21, 1997
- 5-for-3